Biovista partnering with Novartis to identify new indications for undisclosed Novartis compounds using Biovista's Clinical Outcome Search Space (COSS) technology

Biovista Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Novartis AG

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced